Compare NDSN & ZBH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NDSN | ZBH |
|---|---|---|
| Founded | 1935 | 1927 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Industrial Specialties |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 17.7B | 17.6B |
| IPO Year | 1998 | 2001 |
| Metric | NDSN | ZBH |
|---|---|---|
| Price | $322.57 | $95.01 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 7 | 28 |
| Target Price | ★ $349.71 | $106.82 |
| AVG Volume (30 Days) | 307.4K | ★ 1.8M |
| Earning Date | 08-19-2026 | 11-04-2026 |
| Dividend Yield | ★ 1.14% | 1.02% |
| EPS Growth | ★ 4.93 | N/A |
| EPS | ★ 7.20 | 2.25 |
| Revenue | $2,254,668,000.00 | ★ $8,231,500,000.00 |
| Revenue This Year | $9.51 | $4.43 |
| Revenue Next Year | $5.15 | $3.54 |
| P/E Ratio | $45.68 | ★ $41.98 |
| Revenue Growth | ★ 9.08 | 7.20 |
| 52 Week Low | $223.29 | $79.12 |
| 52 Week High | $339.12 | $106.88 |
| Indicator | NDSN | ZBH |
|---|---|---|
| Relative Strength Index (RSI) | 43.84 | 57.01 |
| Support Level | $304.47 | $94.28 |
| Resistance Level | $338.65 | $98.20 |
| Average True Range (ATR) | 5.88 | 1.98 |
| MACD | -1.08 | 0.76 |
| Stochastic Oscillator | 8.51 | 87.73 |
Nordson manufactures equipment (including pumps, valves, dispensers, applicators, filters, and pelletizers) used for dispensing adhesives, coatings, sealants, and other materials. The firm serves a diverse range of end markets, including packaging, medical, electronics, and industrial. Nordson's business is organized into three segments: industrial precision solutions, medical and fluid solutions, and advanced technology solutions. The company generated approximately $2.8 billion in revenue in its fiscal 2025.
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two-thirds of total revenue is derived from sales of large joints; another fourth comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.